Authors

• Lillian L. Siu (ORCID: https://orcid.org/0000-0002-3500-0540)
• Meredith McKean (ORCID: https://orcid.org/0000-0003-0944-7418)
• Aung Naing (ORCID: https://orcid.org/0000-0002-4803-8513)
• Ping Hu (ORCID: https://orcid.org/0000-0002-5779-5743)
• Emilia Richter
• Marco Antonio Ferraz Nogueira Filho (ORCID: https://orcid.org/0000-0002-8290-1114)
• Anja Victor
• Anthony W. Tolcher (ORCID: https://orcid.org/0000-0002-6322-9721)
• Wei Gao (ORCID: https://orcid.org/0009-0004-3149-8486)
• Thomas Kitzing (ORCID: https://orcid.org/0000-0003-3424-4882)
• Daniel J. Holland (ORCID: https://orcid.org/0000-0002-9192-5396)
• Stephan Gleicher
• Keyvan Tadjalli-Mehr

Institutions

• The University of Texas MD Anderson Cancer Center (US)
• Merck KGaA, Darmstadt (Germany) (DE)
• Texas Oncology (US)
• Princess Margaret Cancer Centre (CA)
• Ono Pharmaceutical (United States) (US)
• Sarah Cannon (US)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2025-02-01

DOI

https://doi.org/10.1136/jitc-2024-010584

Citations

6

Primary Topic

CAR-T cell therapy research

Type

article

Field-Weighted Citation Impact

6.27